K140225Substantially Equivalent
Elia Pr3s Immunoassay, Elia Mpos Immunoassay, Elia Gbm Immunoassay, Elia Anca/gbm Positive Control 100, Elia Anca/gbm Po
Phadia AB, Freiburg Im Breisgau, DE / Traditional, Substantially Equivalent
K140225 is the FDA 510(k) clearance record for ELIA PR3S IMMUNOASSAY, ELIA MPOS IMMUNOASSAY, ELIA GBM IMMUNOASSAY, ELIA ANCA/GBM POSITIVE CONTROL 100, ELIA ANCA/GBM PO, a class II device, cleared for Phadia US, Inc. on under FDA product code MOB (Test System, Antineutrophil Cytoplasmic Antibodies (Anca)). FDA records list 56 510(k) clearances for PHADIA AB, from to . As of , FDA records show one recall naming K140225.
Clearance record
- Decision date
- Received
- (271 days to decision)
- Product code
- MOB Test System, Antineutrophil Cytoplasmic Antibodies (Anca)
- Regulation
- 21 CFR 866.5660
- Device class
- Class II
- Review panel
- Immunology
- Applicant
- Phadia US, Inc. Munzinger Strasse 7, Freiburg Im Breisgau, DE
- 510(k) summary
- Summary PDF
- Third party review
- No
Clearances, product code MOB
Trailing 12 monthsShow the numbers
| Month | Clearances |
|---|---|
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 0 |
| March 2026 | 0 |
| April 2026 | 0 |
| May 2026 | 0 |
| June 2026 | 0 |
| July 2026 | 0 |
| August 2026 | 1 |
| September 2026 | 0 |
| October 2026 | 0 |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
